SAMUEL HEATH: Open Payments
NPI 1043937089 · WILLOW GROVE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,097 in 109 payments from 19 companies in 2025. Trend: 2023 $1,297 · 2024 $1,932 · 2025 $3,097
Food & beverage: $2,361Consulting: $736
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 23 | $1,042 |
| Amgen Inc. | 19 | $321 |
| UCB, Inc. | 12 | $315 |
| ABBVIE INC. | 12 | $261 |
| Janssen Biotech, Inc. | 4 | $208 |
| Zimmer Biomet Holdings, Inc. | 2 | $133 |
| PFIZER INC. | 6 | $126 |
| Organon LLC | 6 | $124 |
| Lilly USA, LLC | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $90 |
Products named: Bimzelx, ORENCIA, RINVOQ, TREMFYA, Gel-One Cross-linked Hyaluronate, XELJANZ, HADLIMA, OTEZLA.
Industry payments across PA — which companies pay providers there.
